Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Mctiernan

A Phase II Study of Docetaxel in Patients With Relapsed and Refractory Ewing's Tumours

Nuclear Medicine

English

Related publications

Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma

English

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Journal of Clinical Oncology

Cancer Research

English

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

Journal of Clinical Oncology

Cancer Research

English

A Phase II Trial of Tremelimumab (CP-675,206) in Patients With Advanced Refractory or Relapsed Melanoma

Journal of Clinical Oncology

Cancer Research

English

A Single Center Phase II Study of Ixazomib in Patients With Relapsed or Refractory Cutaneous or Peripheral T-Cell Lymphomas

American Journal of Hematology

English

Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Hematological Oncology

Cancer Research

English

The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study

English

Phase II Study of Docetaxel in Patients With Metastatic Pancreatic Cancer: A Japanese Cooperative Study

British Journal of Cancer

Cancer Research

English

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Hematological Oncology

Cancer Research

English